• Explore /
  • Poster
  • / Association between rigors and overall survival (OS) in metastatic renal cell carcinoma (mRCC) patients treated with high-dose interleukin-2 (HD IL-2).

Association between rigors and overall survival (OS) in metastatic renal cell carcinoma (mRCC) patients treated with high-dose interleukin-2 (HD IL-2).

Abstract Poster

Authors

null

Julia Anne Batten

University of Utah, Huntsman Cancer Institute, Salt Lake City, UT

Julia Anne Batten , Wolfram E. Samlowski , Kinjal Parikh , Arun Sendilnathan , Hilda Crispin , Joan Van Atta , Daniel Sageser , Kenneth F. Grossmann , Junfeng Wang , Srinivas Kiran Tantravahi , David D. Stenehjem , Neeraj Agarwal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Renal Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 32, 2014 (suppl 4; abstr 487)

DOI

10.1200/jco.2014.32.4_suppl.487

Abstract #

487

Poster Bd #

G2

Abstract Disclosures

Similar Posters

First Author: Inge Marie Svane

First Author: Ulka N. Vaishampayan

First Author: Mayer N. Fishman

First Author: Leonard Joseph Appleman